“…This paradigm has consistently shown improvements in behavioral and histological outcome after brain trauma and can therefore be considered a reasonable approach to preclinical rehabilitation. Importantly, the benefits conferred by EE span clinically-relevant models of experimental TBI, such as controlled cortical impact (CCI; Chen et al, 2005;de Witt et al, 2011;Hoffman et al, 2008;Kline et al, 2007Kline et al, ,2010Matter et al, 2011;Sozda et al, 2010) and fluid percussion (Hamm et al, 1996;Hicks et al, 2002;Gaulke et al, 2005;Giza et al, 2005;Maegele et al, 2005;Passineau et al, 2001). The second therapy in this combined treatment approach is the systemic administration of the serotonin 1A (5-HT 1A )-receptor agonist buspirone.…”